NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative ...
Good day and welcome to the LightPath Technologies Inc fiscal fourth-quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn ...
Pending authorization of the Omicron KP.2-adapted vaccine by the EC, both the Omicron KP.2-adapted vaccine and the Omicron JN.1-adapted vaccine will be available across the EU, though availability ...